Home / Import refusals / AEK-8102465-3/21/1

FDA Import Refusal AEK-8102465-3/21/1 — IPR Pharmaceuticals, Inc.

IPR Pharmaceuticals, Inc. — FEI 3003009422

The FDA refused shipment AEK-8102465-3/21/1 from IPR Pharmaceuticals, Inc. (United States) on January 22, 2025. The refused product falls under Drugs and Biologics — ROSUVASTATIN CALCIUM. Cited charges: 118,75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
January 22, 2025
Country
United States
Product Category
Drugs and Biologics
Product Code
61JDA16 ROSUVASTATIN CALCIUM
Charges
118,75

Recent inspections

  • 1271831 (NAI Mon May 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1055499 (VAI Thu Jun 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 942102 (NAI Wed Aug 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 844409 (VAI Mon Jul 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 701582 (NAI Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 799-7648528-6/10001/1 (Mon Nov 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7516272-5/10001/1 (Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-1504412-6/11/1 (Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-7958136-7/21/1 (Mon Oct 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 655-2007255-8/11/1 (Thu Jun 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources